Oral Oncology
Volume 37, Issue 1 , Pages 50-56 , January 2001

Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck

  • T.K Hoffmann

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D40225 Düsseldorf, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-211-811-7570; fax: +49-211-811-8880
    • ,
  • H Balló

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D40225 Düsseldorf, Germany
    • ,
  • S Braunstein

      Affiliations

    • Department of Pathology, Heinrich-Heine-University, Moorenstr. 5, D-40225 Düsseldorf, Germany
    • ,
  • A Van Lierop

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D40225 Düsseldorf, Germany
    • ,
  • M Wagenmann

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D40225 Düsseldorf, Germany
    • ,
  • H Bier

      Affiliations

    • Department of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D40225 Düsseldorf, Germany

Received 10 February 2000 ,Accepted 13 March 2000.

References 

  1. Cohen S, Fava R, Sawyer ST. Purification and characterization of epidermal growth factor receptor protein kinase from mouse liver. Proceedings of the National Academy of Science. 1982;79:6237–6241
  2. Ullrich A, Coussens L, Hayflick JS, et al.  Human epidermal growth factor receptor cDNA sequence and aberant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 1984;309:418–425
  3. In:  Sporn MB,  Roberts AB editor. Peptide growth factors and their receptors. Berlin: Springer; 1991;
  4. Schechter AL, Stern DF, Vaidyanathan L, et al.  The neu oncogene (an erb-B-related gene encoding a 185,000 Mr tumour antigen). Nature. 1984;312:513–516
  5. Aaronson SA. Growth factors and cancer. Science. 1991;254:1146–1152
  6. Schlessinger J, Ullrich A. Growth factor signalling by receptor tyrosine kinases. Cell. 1992;9:383–388
  7. Cowley GP, Smith JA, Gusterson BA. Increased EGF receptors on human squamous carcinoma cell lines. British Journal of Cancer. 1986;53:223–229
  8. Ozanne B, Richards CS, Hendler F, Burns D, Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. Journal of Pathology. 1986;149:9–14
  9. Partridge M, Gullick WJ, Langdon JD, Sheriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinomas. British Journal of Oral and Maxillofacial Surgery. 1988;26:381–386
  10. Bergler W, Bier H, Ganzer U. The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Archives of Otorhinolaryngology. 1989;246:121–125
  11. Santini J, Formento J, Francoual M, et al.  Characterization, quantification and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 1991;13:132–139
  12. Khazaie K, Schirmacher V, Lichtner RB. EGF receptor in neoplasia and metastasis. Cancer Metastasis Review. 1993;12:255–274
  13. Dassonville O, Formento JL, Francoual M, et al.  Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. Journal of Clinical Oncology. 1993;11:1873–1878
  14. Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexo E. A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. British Journal of Cancer. 1995;72:1487–1493
  15. Bier H, Reiffen KA, Haas I, Stasiecki P. Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumour cells in patients with advanced laryngeal and hypopharyngeal carcinoma. European Archives of Otorhinolaryngology. 1995;252:433–439
  16. Bier H, Hoffmann I. Epidermal growth factor receptor in head and neck squamous cell carcinomas. In:  Werner JA,  Lippert BM,  Rudert HH editor. Head and Neck Cancer — Advances in Basic Research, Excerpta Medica International Congress Series 1114. Amsterdam: Elsevier; 1996;p. 225–234
  17. Grandis JR, Melhem MF, Gooding WE, et al.  Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. Journal of the National Cancer Institute. 1998;90:824–832
  18. Kearsley JH, Lenoard JH, Walsh MD, Wright GR. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas. Pathology. 1991;23:189–194
  19. Reviére A, Becker J, Loning T. Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer. 1991;67:2142–2149
  20. Craven JM, Pavelic ZP, Stambrook PJ, et al.  Expression of c-erbB-2 in human head and neck carcinoma. Anticancer Research. 1992;12:2273–2276
  21. Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papaimitriou K, Stell PM. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Research. 1992;12:613–620
  22. Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D. Oral cancer progression and cerbB-2/neu proto-oncogene expression. Cancer Letters. 1992;65:215–220
  23. Beckhardt R, Kiyokowa N, Xi L, et al.  HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Archives of Otolaryngology Head Neck Surgery. 1995;121:1265–1270
  24. Ibrahim SO, Lillehaug JR, Johannessen AC, Liavaag PG, Nilsen R, Vasstrand EN. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncology. 1999;35:302–313
  25. Chiesa F, Mauri S, Tradati N, et al.  Surfing prognostic factors in head and neck cancer at the millenium. Oral Oncology. 1999;35:590–596
  26. Mayes ELV, Waterfield MD. Biosynthesis of the epidermal growth factor receptor in A431 cells. The EMBO Journal. 1984;3:531–537
  27. Zabrecky JR, Lam T, McKenzie SJ, Carney W. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. Journal of Biological Chemistry. 1991;266:1716–1720
  28. Leitzel K, Teramoto Y, Sampson E, et al.  Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a portion of breast cancer patients. Journal of Clinical Oncology. 1992;10:1436–1443
  29. Wu JT, Astill ME, Zhang P. Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers. Journal of Clinical Laboratory Analysis. 1993;7:31–40
  30. Isola JJ, Holli K, Oksa H, Teramoto Y, Kallioniemi O-P. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer. 1994;73:652–658
  31. Kandl H, Seymour L, Bezwoda WR. Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. British Journal of Cancer. 1994;70:739–742
  32. Partanen R, Hemminki K, Koskinen H, Luo J-C, Carney WP, Brandt-Rauf PW. The detection of inreased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. Journal of Occupational Medicine. 1994;36:1324–1328
  33. Andersen TI, Paus E, Nesland JM, McKenzie SJ, Borresen AL. Detection of c-erbB-2 related protein in sera from breast cancer patients. Acta Oncologica. 1995;34:499–504
  34. Osaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest. 1995;108:157–162
  35. Choi JH, Oh JY, Ryu SK, et al.  Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer. 1997;79:1879–1883
  36. Mansour OA, Zekri AR, Harvey J, Teramoto Y, el-Alnnady O. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up. Anticancer Research. 1997;17:3101–3106
  37. Venter DJ, Tuzi NL, Kumar S, Gullick WJ. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet. 1987;11:69–72
  38. Pupa SM, Menard S, Andreola S, Colnaghi MI. Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Research. 1993;53:5864–5866
  39. Molina R, Jo J, Filella X, et al.  Serum levels of c-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases. Tumor Biology. 1997;18:188–196

PII: S1368-8375(00)00056-7

Oral Oncology
Volume 37, Issue 1 , Pages 50-56 , January 2001

Article Tools

* Image Usage & Resolution